• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.98% Nasdaq Down 0.94%

    AbbVie Inc. (ABBV)

    -NYSE
    63.57 Down 0.29(0.45%) 2:40PM EDT - NYSE Real Time Price
    Add to Portfolio
    Prev Close:63.86
    Open:64.11
    Bid:63.68 x 300
    Ask:63.69 x 200
    1y Target Est:72.09
    Beta:1.66
    Earnings Date:Jul 23 - Jul 27 (Est.)
    Day's Range:63.40 - 64.53
    52wk Range:51.08 - 70.76
    Volume:5,786,395
    Avg Vol (3m):12,573,400
    Market Cap:101.21B
    P/E (ttm):57.79
    EPS (ttm):1.10
    Div & Yield:2.04 (3.30%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Headlines

    » More Headlines for ABBV

    Comparison

    Symbol% ChgMkt Cap
    ABBVDown 0.45%101.21B
    MRKDown 0.76%169.79B
    NVSDown 0.75%245.42B
    PFEDown 1.75%204.14B

    Key Statistics

    Forward P/E (1 yr):12.90
    P/S (ttm):4.98
    Ex-Dividend Date:13-Apr-15

    Analysts

    Annual EPS Est (Dec-15) :4.23
    Quarterly EPS Est (Jun-15) :1.06
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):1.01

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products include HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; VIEKIRA PAK, an all-o... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback